Screening of Differential Genes for Endometriosis and Expression Validation of the Potential Target GAS6
10.13865/j.cnki.cjbmb.2021.04.1016
- Author:
Chang LIU
1
;
Tai-Hang LIU
1
;
Yu-Bin DING
1
;
Fang-Fang LI
1
;
Fan HE
2
;
Yu-Gang CHI
3
;
Bo-Ping YANG
3
;
Shi-Quan XIAO
4
Author Information
1. Joint International Research Laboratory of Reproduction & Development, School of Public Health and Management, Chongqing Medical University
2. Reproductive Center of the Second Affiliated Hospital of Chongqing Medical University
3. Department of Gynecology, Chongqing Maternal and Child Health Hospital
4. Reproductive Medicine Center of Third Affiliated Hospital of Chongqing Medical University
- Publication Type:Journal Article
- Keywords:
differential genes;
endometriosis (EMs);
epithelial mesenchymal transition (EMT);
growth arrest specific protein 6 (GAS6)
- From:
Chinese Journal of Biochemistry and Molecular Biology
2021;37(7):91-926
- CountryChina
- Language:Chinese
-
Abstract:
Growth arrest specific protein 6 (GAS6) plays an important role in the occurrence and development of tumors, and its signal transduction is involved in cell proliferation, adhesion and migration, but its related functions and molecular mechanisms in endometriosis (EMs) are still unclear. In this study, we searched and downloaded the transcriptome datasets of EMs from GEO database and performed GEO online analysis, and then screened out the differentially expressed genes and performed cluster analysis based on GO and KEGG pathway. The mRNA levels of the differentially expressed genes shared by more than three datasets were verified by qRT-PCR in the endometrium of ten women with no endometriosis and no clear disease and the ectopic endometrium of 11 patients with ovarian chocolate cysts. Immunohistochemistry and qRT-PCR were used to verify the expression of GAS6 and epithelial mesenchymal transition (EMT) marker genes, and immunofluorescence was used to co-label GAS6 and E-cadherin in endometriosis clinical samples. In this study, a total of 47 differentially expressed genes were screened out of the four transcriptome datasets, which were mainly enriched in processes such as cell migration and related signal pathways such as MAPK, PI3K-AKT, and tight junction. The mRNA levels of the nine differentially expressed genes shared by more than three datasets in endometriosis patients were consistent with the results of bioinformatics analysis. GAS6 expression levels in ectopic endometrium of EMs patients are higher than the control group (P < 0. 05), and EMs patients have the characteristics of EMT in the ectopic endometrial tissue, that is, the expression of E-cadherin is down-regulated (P < 0. 05) and the expression of vimentin is up-regulated (P < 0. 01). The expression of E-cadherin in the ectopic endometrial glandular epithelial cells of EMs patients is low while the expression of GAS6 is up-regulated, suggesting that GAS6 may mediate the EMT process in endometriosis. In conclusion, this study reveals that GAS6 is highly expressed in endometriosis patients and may mediate the EMT process to participate in the occurrence and development of endometriosis, providing a potential target for clinical treatment of endometriosis.
